241-255 of 825
Preventing Alzheimer’s Disease Through Lifestyle Interventions
NeuroFrontiersPreventing Alzheimer’s Disease Through Lifestyle Interventions
Michele Longo, MD
Amyloid-Targeted Therapies: A New Era in Alzheimer’s Disease Treatment
NeuroFrontiersAmyloid-Targeted Therapies: A New Era in Alzheimer’s Disease Treatment
Michele Longo, MD
Transforming Schizophrenia Treatment: Advances in Medication and Therapy
NeuroFrontiersTransforming Schizophrenia Treatment: Advances in Medication and Therapy
Robert Walker, PharmD
Deanna L. Kelly, PharmD, BCPP
Advancing Schizophrenia Care: Challenges and Promising New Therapies
NeuroFrontiersAdvancing Schizophrenia Care: Challenges and Promising New Therapies
Charles Turck, PharmD, BCPS, BCCCP
Andrew J. Cutler, MD
Peter Buch, MD, FACG, AGAF, FACP
Douglas Drossman, MD
Debunking Misconceptions Regarding the Revised Alzheimer’s Diagnostic Criteria
NeuroFrontiersDebunking Misconceptions Regarding the Revised Alzheimer’s Diagnostic Criteria
Clifford Jack Jr., MD
- advertisement
Reviewing the Revised Alzheimer’s Diagnostic Criteria: The Role of Biomarkers
NeuroFrontiersReviewing the Revised Alzheimer’s Diagnostic Criteria: The Role of Biomarkers
Clifford Jack Jr., MD
Beyond the Brain Scan: Blood-Based Biomarker Tests for Alzheimer’s Detection
NeuroFrontiersBeyond the Brain Scan: Blood-Based Biomarker Tests for Alzheimer’s Detection
Ashley Baker, MSN, PMHNP
Suzanne E. Schindler, MD, PhD
Diagnosing Myasthenia Gravis: The Impact of Social Media
Clinician's RoundtableDiagnosing Myasthenia Gravis: The Impact of Social Media
Ashley Baker, MSN, PMHNP
Vishnu Pandurangadu, MD/MBA, FACEP
Pritikanta Paul, MD
Schizophrenia and Heart Health: Navigating the Hidden Risk of Sudden Cardiac Death
NeuroFrontiersSchizophrenia and Heart Health: Navigating the Hidden Risk of Sudden Cardiac Death
Zilucoplan: A Promising Potential Treatment for Myasthenia Gravis
NeuroFrontiersZilucoplan: A Promising Potential Treatment for Myasthenia Gravis
The Role of Augmented Intelligence in Electrodiagnostic and Neuromuscular Medicine
NeuroFrontiersThe Role of Augmented Intelligence in Electrodiagnostic and Neuromuscular Medicine
John A. Morren, MD, FAAN, FAANEM
- advertisement
Bridging the Gap to Improved Schizophrenia Treatment Options
NeuroFrontiersBridging the Gap to Improved Schizophrenia Treatment Options
Reducing the ALS Diagnostic Delay: The Impacts of a Rapid Access Clinic
NeuroFrontiersReducing the ALS Diagnostic Delay: The Impacts of a Rapid Access Clinic
Kelly G. Gwathmey, MD
The BALTAZAR Study: How Caffeine Intake Affects Alzheimer's Biomarkers
NeuroFrontiersThe BALTAZAR Study: How Caffeine Intake Affects Alzheimer's Biomarkers
